Many studies have recently reported reactivation in hepatitis B surface antigen (HBsAg)-negative subjects with the use of biologic agents such as rituximab. However, occult hepatitis B virus infection itself has little clinical impact. We experienced a case of acute exacerbation caused by occult hepatitis B infection without HBsAg seroconversion. No mutation was found on the major hydrophilic loop of the S protein. The patient recovered from acute exacerbation after antiviral therapy. In conclusion, acute exacerbation can be induced by occult hepatitis B virus infection itself without reactivation. In such a case, antiviral therapy should be considered. ( 
RCHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) increased after RCHOP treatment, serum hepatitis B virus (HBV) DNA level was 1180 IU/mL, and the patient was HBsAg (-), anti-HBs (-), and HBcAb IgM (+). AST and ALT levels decreased after anti-viral treatment with entecavir, and HBV DNA was within the normal range. 중심 단어: 비형간염; 재활성화; 비형간염표면항원
